Challenges for the development of drugs with low aqueous solubility and/or low permeability

Monday 14th of April 2014
10:30-12:00
SY08, 1.5 hours

Chair: Val Stella (USA)

Meeting room 210

10.30 – 11.00     Solubility and formulate-ability: Key molecular determinants of developability of ligands to contemporary targets
(MO-10-01) Christel Bergstrom, Uppsala University, Uppsala, Sweden

11.00 – 11.30     Development of oral drug product based on BCS concept; integrating drug permeability, solubility and dissolution
(MO-10-02) Shinji Yamashita, Setsunan University, Neyagawa, Japan

11.30 – 12.00     Solubilization for oral drug delivery: new challenges in prediction
(MO-10-03) Bradley Anderson, University of Kentucky, United States